https://www.gosh.nhs.uk/news/gosh-ranked-4th-north-thames-region-clinical-trial-activity/

​GOSH ranked fourth in North Thames region for clinical trial activity

2 Aug 2017, 1:33 p.m.

GOSH patient with a research nurse

Great Ormond Street Hospital for Children NHS Foundation Trust (GOSH) has been ranked 4th in the North Thames region for number of active clinical research studies in 2016/17, in figures released today by the National Institute for Health Research (NIHR).

The 2016/17 statistics show that GOSH recruited 2,704 patients to 163 studies, placing the Hospital 30th out of 449 Trusts in the UK, and amongst the most research-active acute specialist NHS Trusts.

Emma Pendleton, Deputy Director of Research and Innovation at GOSH, said, “These impressive figures recognise the expertise of our researchers as well as our commitment to ensuring our patients are given the opportunity to take part in research studies relevant to their condition. We will continue to push the boundaries to ensure that GOSH patients, as well families around the globe, can benefit from our pioneering research into children’s medicine".

Many of the clinical trials at GOSH are highly intensive, early phase studies which aim to translate the discoveries made in the laboratory into innovative ways to diagnose and treat children with some of the rarest and most complex childhood conditions. GOSH’s expertise in experimental medicine was recognised in April this year with the award of £40 million of NIHR funding to the GOSH Biomedical Research Centre and GOSH Clinical Research Facility, to support our ground breaking research over the next five years.

The League Table figures include projects supported by the NIHR’s North Thames Clinical Research Network, a prestigious network that supports research across the NHS. GOSH also runs many more research projects from basic science to late phase clinical trials.

In the North Thames region 2,141 clinical research studies were open in 2016/17 recruiting 63,588 participants. These participants joined over 665,000 participants nationally, the highest numbers since the launch of the League Table. More details are available from the NIHR.

Important step forward in stem cell therapy for rare bowel disease

A new study led by researchers at UCL Great Ormond Street Institute of Child Health (UCL GOS ICH) and the Centre for Stem Cell Biology, University of Sheffield, has demonstrated the potential of stem cell therapy to treat those with Hirschsprung disease.

First UK trial of Deep Brain Stimulation for children with epilepsy begins at GOSH

Discover how Oran became the first UK patient in a clinical trial using deep brain stimulation (DBS) for epilepsy. Learn about his 80% reduction in daytime seizures thanks to this innovative DBS treatment.

Studying the impact of environments on child health by linking big data

At GOSH we know that we're not caring for children if we're not caring for the environment. We spoke to Professor Pia Hardelid, who told us about a project which is helping us to understand the impacts of local environments on children’s health.

Blood test and AI could predict Parkinson’s seven years before symptoms

International researchers have developed a simple blood test that uses artificial intelligence to predict Parkinson’s up to seven years before the onset of symptoms, part-supported by the NIHR GOSH BRC